IL130808A0 - Antibodies that bind to the nidogen-binding domain of laminin their production and use - Google Patents

Antibodies that bind to the nidogen-binding domain of laminin their production and use

Info

Publication number
IL130808A0
IL130808A0 IL13080897A IL13080897A IL130808A0 IL 130808 A0 IL130808 A0 IL 130808A0 IL 13080897 A IL13080897 A IL 13080897A IL 13080897 A IL13080897 A IL 13080897A IL 130808 A0 IL130808 A0 IL 130808A0
Authority
IL
Israel
Prior art keywords
nidogen
laminin
antibodies
bind
production
Prior art date
Application number
IL13080897A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL130808A0 publication Critical patent/IL130808A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL13080897A 1997-01-17 1997-12-22 Antibodies that bind to the nidogen-binding domain of laminin their production and use IL130808A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19701607A DE19701607A1 (de) 1997-01-17 1997-01-17 Anitkörper, die an die Nidogen-Bindungsdomäne des Laminins binden, deren Herstellung und Verwendung
PCT/EP1997/007241 WO1998031709A1 (de) 1997-01-17 1997-12-22 Antikörper, die an die nidogen-bindungsdomäne des laminins binden, deren herstellung und verwendung

Publications (1)

Publication Number Publication Date
IL130808A0 true IL130808A0 (en) 2001-01-28

Family

ID=7817701

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13080897A IL130808A0 (en) 1997-01-17 1997-12-22 Antibodies that bind to the nidogen-binding domain of laminin their production and use

Country Status (18)

Country Link
US (1) US20010007020A1 (cs)
EP (1) EP0954535A1 (cs)
JP (1) JP2001509020A (cs)
KR (1) KR20000070256A (cs)
CN (1) CN1244873A (cs)
AR (1) AR011074A1 (cs)
AU (1) AU5985398A (cs)
BR (1) BR9714207A (cs)
CA (1) CA2278477A1 (cs)
CZ (1) CZ253899A3 (cs)
DE (1) DE19701607A1 (cs)
HU (1) HUP0001808A3 (cs)
ID (1) ID21895A (cs)
IL (1) IL130808A0 (cs)
PL (1) PL334956A1 (cs)
TR (1) TR199901648T2 (cs)
WO (1) WO1998031709A1 (cs)
ZA (1) ZA98367B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087318A1 (en) * 1994-04-18 2003-05-08 Lallone Roger L. Antibodies against an extracellular matrix complex and their use in the detection of cancer
EP1070727A1 (en) 1999-03-01 2001-01-24 Aventis Pharma Deutschland GmbH Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
CA2389751A1 (en) * 1999-11-01 2001-05-10 Curagen Corporation Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
WO2001061349A1 (en) * 2000-02-18 2001-08-23 The University Of Tennessee Research Corporation Detection of microbial deposition and immune response at the basement membrane
ATE331785T1 (de) * 2000-03-29 2006-07-15 Beth Israel Hospital Anti-angiogenic properties of matin and of fragments or variants thereof
US20030119739A1 (en) * 2000-03-29 2003-06-26 Beth Israel Deaconess Medical Center Anti-angiogenic and anti-tumor properties of Vascostatin and other nidogen domains
WO2004093892A2 (en) 2003-04-16 2004-11-04 Genentech, Inc. Stanniocalcin-1, variant or antagonists thereof for selective modulation of vascularization
US20140045196A1 (en) * 2012-08-13 2014-02-13 University Of Tokyo Methods of prognosis and diagnosis of cancer
CN110860766A (zh) * 2019-10-22 2020-03-06 广东开放大学（广东理工职业学院） 铝合金薄板的调制脉冲电流焊接方法、系统及存储介质

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211657A (en) * 1988-11-07 1993-05-18 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
ES2459290T3 (es) * 1994-08-11 2014-05-08 Sanofi-Aventis Deutschland Gmbh Anticuerpos monoclonales para la determinación inmunológica selectiva de formas de lamininas de alto peso molecular en líquidos corporales
US5493008A (en) * 1994-08-15 1996-02-20 The University Of Virginia Patent Foundation Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain

Also Published As

Publication number Publication date
CN1244873A (zh) 2000-02-16
BR9714207A (pt) 2000-03-28
ZA98367B (en) 1998-07-17
CA2278477A1 (en) 1998-07-23
HUP0001808A2 (hu) 2000-09-28
US20010007020A1 (en) 2001-07-05
TR199901648T2 (xx) 1999-10-21
WO1998031709A1 (de) 1998-07-23
HUP0001808A3 (en) 2001-09-28
PL334956A1 (en) 2000-03-27
JP2001509020A (ja) 2001-07-10
AR011074A1 (es) 2000-08-02
AU5985398A (en) 1998-08-07
EP0954535A1 (de) 1999-11-10
DE19701607A1 (de) 1998-07-23
KR20000070256A (ko) 2000-11-25
ID21895A (id) 1999-08-05
CZ253899A3 (cs) 1999-10-13

Similar Documents

Publication Publication Date Title
IL144578A0 (en) Antibodies specific to kdr and uses thereof
HUP1500179A2 (en) The use of human tnf-alpha binding antibodies
EG21397A (en) Improved in the production of spun-bonded web
ID26590A (id) Komposisi-komposisi dua fasa bebas pewangi dan metode-metode untuk menurunkan bau badan dan lingkungan
ID21859A (id) Bahan lembaran serupa-kulit dan metode untuk memproduksi bahan tersebut
ID19290A (id) Turunan-turunan propiofenon dan proses pembuatannya
AP2000001983A0 (en) Antibodies to cd23 derivatives thereof and their therapeutic uses
NO20003394L (no) Fremgangsmate for fremstilling av syntetiske silikater og anvendelse derav i glassproduksjon
ID19878A (id) Kemasan untuk tumpukan lembaran dan proses pembuatannya
AU6949800A (en) Compositions and methods for the treatment of sepsis using antibodies to c5a
PL341569A1 (en) Monoclonal anti-alphav-integrin antibody and application thereof as an inhibitore of alphavbeta6-integrin to fibronectin bond
EP0804339A4 (en) DECORATIVE CONSTRUCTION MATERIAL AND METHODS OF MAKING SAME
IL130808A0 (en) Antibodies that bind to the nidogen-binding domain of laminin their production and use
ZA985457B (en) Isolated nona- and decapeptides which bind to HLA molecules and the use thereof
GB9615682D0 (en) The process of asphalt purification and the composition of modified asphalt
NZ298241A (en) Preparation of intermediates in the synthesis of cephalosporins
GB2301377B (en) The manufacture of composite materials
IL129909A0 (en) Novel calpaines their production and use thereof
EP0759976A4 (en) THE INSULATION AND PRODUCTION OF CATALYTIC ANTIBODIES USING PHAGENTECHNOLOGY
ZA967742B (en) The use of cytohesin-ph peptides for influencing the ability of integrins to adhere
FI964854A7 (fi) Hydroksitioasetamidien valmistus ja niiden käyttö bentsotiofeenien syn teesissä
EP0934063A4 (en) USE OF SIALIDASE ANTIBODIES AS ANTI-INFECTIOUS AND ANTI-INFLAMMATORY AGENTS
GB9712410D0 (en) Peptides and compounds that bind to the il-5 receptor
EP1070081A4 (en) NEW PROTEINS OF THE FAMILY OF PROTEINS T129 AND USES THEREOF
GB9708932D0 (en) Improvements in and relating to the manufacture of snack products